These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32312496)

  • 1. Diagnostic and therapeutic issues of inflammatory diseases of the elderly.
    Ayrignac X; Carra-Dallière C; Labauge P
    Rev Neurol (Paris); 2020 Nov; 176(9):739-749. PubMed ID: 32312496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
    Wingerchuk DM; Lucchinetti CF
    Curr Opin Neurol; 2007 Jun; 20(3):343-50. PubMed ID: 17495631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of multiple sclerosis: progress and challenges.
    Brownlee WJ; Hardy TA; Fazekas F; Miller DH
    Lancet; 2017 Apr; 389(10076):1336-1346. PubMed ID: 27889190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis.
    Dale RC; Brilot F; Banwell B
    Curr Opin Neurol; 2009 Jun; 22(3):233-40. PubMed ID: 19434783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders.
    Cavalla P; Caropreso P; Limoncelli S; Bosa C; Pasanisi MB; Schillaci V; Alteno A; Costantini G; Giordana MT; Mengozzi G; Vercellino M
    J Neuroimmunol; 2020 Feb; 339():577122. PubMed ID: 31837636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic criteria of borderline forms of multiple sclerosis].
    Dupel-Pottier C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):935-43. PubMed ID: 11787358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuromyelitis optica].
    Ferrán C; Pedemonte V; Turcatti E; González G
    Medicina (B Aires); 2019; 79 Suppl 3():60-65. PubMed ID: 31603846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania.
    Sakalauskaitė-Juodeikienė E; Armalienė G; Kizlaitienė R; Bagdonaitė L; Giedraitienė N; Mickevičienė D; Rastenytė D; Kaubrys G; Jatužis D
    Brain Behav; 2018 Nov; 8(11):e01129. PubMed ID: 30284401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.
    van Rooij LC; Wattjes MP; de Jong BA; van Oosten BW
    Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Devic's neuromyelitis optica and related neurological disorders].
    Marignier R; Confavreux C
    Presse Med; 2010 Mar; 39(3):371-80. PubMed ID: 20116202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can a diagnosis of multiple sclerosis be made without ruling out neuromyelitis optica spectrum disorder ?
    Avasarala J; Pettigrew C; Sutton P; Guduru Z; Gurwell J; Sokola BS; Mullins S
    Mult Scler Relat Disord; 2020 May; 40():101949. PubMed ID: 31986427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders.
    Häusser-Kinzel S; Weber MS
    Front Immunol; 2019; 10():201. PubMed ID: 30800132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of Central Nervous System Demyelinating Disorders.
    Balashov K
    Continuum (Minneap Minn); 2016 Oct; 22(5, Neuroimaging):1613-1635. PubMed ID: 27740991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent gains in clinical multiple sclerosis research.
    Runia TF; van Pelt-Gravesteijn ED; Hintzen RQ
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):497-505. PubMed ID: 22583434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
    Kuchling J; Paul F
    Front Neurol; 2020; 11():450. PubMed ID: 32625158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the spectrum of neuromyelitis optica: friend or foe?
    Behbehani R
    Curr Opin Ophthalmol; 2007 Nov; 18(6):459-62. PubMed ID: 18162996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Pediatric Demyelinating Diseases of the Central Nervous System.
    Troxell RM; Christy A
    Curr Neurol Neurosci Rep; 2019 Nov; 19(12):95. PubMed ID: 31773416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.
    Dos Passos GR; Sato DK; Becker J; Fujihara K
    Mediators Inflamm; 2016; 2016():5314541. PubMed ID: 26941483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.
    Juryńczyk M; Craner M; Palace J
    J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):20-5. PubMed ID: 25248365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.